Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Thomas Patrick Kelly

CFO at Xenon Pharmaceuticals Inc. (XENE)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$13K
Total bought / sold$560K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Oct 1SEC XENEXenon Pharmaceuticals Inc. Buy 15,000new position $37.32 $560K -2.3%
  • Buy

    CFO Thomas Patrick Kelly bought $560K of XENE at $37.32 — first open-market purchase in our records; opens a new position.